JPM vs PDLB
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
JPM exhibits a concerning Piotroski F-Score of 2/9, indicating weak short-term fundamental health, and currently trades at a significant premium to both its Graham Number ($239.11) and Intrinsic Value ($140.07). While the company maintains a strong ROE of 16.13% and dominant market positioning, negative YoY earnings growth (-3.60%) and bearish insider activity from the CEO and CFO signal internal caution. The stock's current price of $313.68 suggests the market is pricing in a growth premium that is not currently supported by the deterministic health or value metrics.
PDLB presents a compelling value opportunity, trading at $17.53, which is below both its Graham Number ($19.29) and its growth-based Intrinsic Value ($35.4). While the Piotroski F-Score of 4/9 indicates only stable financial health and ROE is relatively low for the banking sector, the company is experiencing explosive earnings growth (264.10% YoY) and consistent earnings beats. The primary headwinds are technical and sentimental, as evidenced by a bearish technical trend and minimal insider buying. Fundamentally, the stock is undervalued relative to its current growth trajectory.
Compare Another Pair
Related Comparisons
JPM vs PDLB: Head-to-Head Comparison
This page compares JPMorgan Chase & Co. (JPM) and Ponce Financial Group, Inc. (PDLB) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.